NEW YORK, June 24 Reportlinker.com announces that a new market research report is available in its catalogue:
Global Interventional Cardiology Industry
Advertisement
http://www.reportlinker.com/p0209273/Global-Interventional-Cardiology-Industry.html
This report analyzes the worldwide markets for Interventional Cardiology in US$ Million. The market for Interventional Cardiology Devices is analyzed by the following product segments: Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings/ Vascular Closure Devices, and Others. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles 73 companies including many key and niche players such as Abbott Laboratories, Abbott Vascular, AGA Medical Holdings, Inc., B. Braun Melsungen AG, Biosensors International Group Ltd., Boston Scientific Corporation, Cardiac Dimensions, Inc., COOK Medical, Inc., Cordis Corporation, Edwards Lifesciences Corp., Eurocor GmbH, ev3, Inc., Goodman Co., Ltd., Medtronic, Inc., Medtronic Vascular, Inc., Merit Medical Systems, Inc., NMT Medical, Spectranetics Corporation, St. Jude Medical, Inc., Terumo Corporation, Terumo Medical Corporation, Thermocore Medical Limited, Translumina GmbH, Vascular Solutions, Inc., and Volcano Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Advertisement
INTERVENTIONAL CARDIOLOGY MCP-6286
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Coronary Stents I-4
Peripheral Devices I-4
Angioplasty Catheters I-4
Intravascular Ultrasound I-4
Vascular Sealings/ Vascular Closure Devices I-4
Others I-5
II. EXECUTIVE SUMMARY
1. GLOBAL MARKET REVIEW II-1
Table 1: Global Coronary Heart Disease Prevalence by Region
(includes corresponding Graph/Chart) II-1
Interventional Cardiology: An Introduction II-1
Coronary Artery Disease - The Leading Cause for Interventional
Cardiology Procedures II-2
Table 2: Deaths Due to Major Cardiovascular Diseases in the
US: Percentage Share Breakdown by Disease Type (includes
corresponding Graph/Chart) II-2
Market Estimates and Forecasts II-2
Geographic Market Performance II-3
Product Segment Review II-3
Market Overview II-3
Interventional Cardiology Technology Prospects II-4
Coronary Stents - The Leading Interventional Cardiology Device
Segment II-4
Table 3: World Coronary Stents Market (2006-2011): Percentage
Breakdown of Value Sales by Stent Type for Bare-Metal Stents
and Drug-eluting Stents (includes corresponding Graph/Chart) II-4
Table 4: World Bare Metal Stents Market (2007-2010):
Percentage Breakdown of Value Sales by Geographic Region -
US, Japan, Europe, Asia-Pacific and Rest of World (includes
corresponding Graph/Chart) II-5
Drug-Eluting Stents - The Best-Selling Coronary Stents II-5
Table 5: World Drug-Eluting Stents Market (2007-2010):
Percentage Breakdown of Value Sales by Geographic Region -
US, Japan, Europe, Asia-Pacific and Rest of World (includes
corresponding Graph/Chart) II-6
Drug-Eluting Stents Market Bounces Back II-6
Cypher And Taxus Dominate Global DES Market II-6
Drug Eluting Stent System - Safety Concerns II-7
Bare Metal Coronary Stents II-7
IVUS Devices - The Fastest Growing Segment II-7
Vascular Sealings - A Fast Growing IC Segment II-8
Future Prospects Of Vascular Sealings II-8
Embolic Protection Devices - Improving PCI Outcomes In SVG
Procedures II-8
DES Opportunities For Smaller Players II-9
2. MARKET TRENDS & ISSUES II-10
Aging Population Propels Coronary Stent Market II-10
Table 6: Aging Population in the US by Age Group for Years
1990-2030 (includes corresponding Graph/Chart) II-10
Next Generation Stents - A Boon for Treating Coronary Diseases II-10
Balloon Angioplasty Wins Edge Over Conventional Bypass Surgery II-11
Interventional Cardiology Procedural Volume Recording Steady
Growth II-11
Technological Advancements to Drive Growth II-11
Lack of Pharmacological Alternatives Boost Demand for
Cardiovascular Catheters II-12
Molding Material and Technology Advancements II-12
Diagnostic Catheters - Advance from the Workhorse 8 Fr. II-12
Smaller Shafts and Colors - The New in Catheters II-12
Coronary Stents Market Challenged by Drug Therapy II-12
PTCA Catheters - Affected by Direct Stenting II-13
Angioplasty - Under Price Pressure II-13
Restenosis - The Unsolved Problem II-13
Cell Transplantation - A Major Threat to Coronary Stents II-14
Repeat Interventional Procedures Affected by the Advent of
Drug-Eluting Stents II-14
Energy-Based Solutions Compete with Conventional
Interventional Systems II-14
New Pharmacological Therapies Minimizing the Need for
Interventional Procedures II-14
3. COMPETITIVE LANDSCAPE II-15
The BIG Four II-15
Major Interventional Cardiology Device Players II-15
Coronary Stents - Leading Players II-16
Table 7: World Coronary Stents Market by Leading Players
(2009-2011): Market Share Breakdown for Boston Scientific,
Abbott/Guidant, Johnson & Johnson , Medtronic, and Others
(includes corresponding Graph/Chart) II-17
Bare Metal Stents - Leading Players II-18
Table 8: World Bare Metal Stents Market (2009-2011):
Percentage Breakdown of Revenues by Leading Players -
Abbott/Guidant, Medtronic, Boston Scientific, Johnson &
Johnson and Others (includes corresponding Graph/Chart) II-18
Drug-Eluting Stents - Leading Players II-19
Table 9: World Drug Eluting Stents Market (2009-2011):
Market Share Breakdown by Leading Players - Boston
Scientific, Abbott/Guidant, Johnson & Johnson, Medtronic and
Others (includes corresponding Graph/Chart) II-19
4. OVERVIEW OF INTERVENTIONAL CARDIOLOGY II-20
CARDIOLOGY II-20
Interventional Cardiology II-20
The Ideal Candidate for Interventional Cardiology II-21
Interventional Cardiology Benefits II-21
Interventional Cardiology Risks II-21
Certain Cardiovascular Diseases for Interventional Cardiology II-22
Coronary Artery Disease II-22
Peripheral Arterial Disease II-22
Heart Valve Disease II-22
Interventional Cardiology Procedures II-23
Cardiac Catheterization II-23
Coronary Angioplasty II-23
Table 10: World Angioplasty and Stent Procedures in Millions
(2007-2011) (includes corresponding Graph/Chart) II-23
Valvuloplasty II-24
Percutaneous Valve Replacement II-24
Coronary Thrombectomy II-24
Cardiac Ablation II-24
Atherectomy II-25
Interventional Cardiology Devices II-25
Coronary Stents II-25
Bare Metal Stents II-25
Select Leading Bare-Metal Stents by Company II-26
Drug Eluting Stents II-26
Select Leading Drug-Eluting Stents by Company II-27
Drugs for Coating DESs II-27
Select Leading Coronary Stent Brands II-27
Cypher II-27
Structure and Delivery Mechanism II-28
Taxus II-28
Structure and Delivery Mechanism II-28
Catheters II-29
Angiography Catheters II-29
PTCA Catheters II-29
Types of Balloon Catheters II-30
Rapid -Exchange PTCA Balloon Catheter II-30
Over-The-Wire PTCA Balloon Catheter II-30
Peripheral Devices II-30
Intravascular Ultrasound II-31
Vascular Sealings/ Vascular Closure Devices II-31
Embolic Protection Devices II-31
Others II-32
Atherectomy Catheters II-32
Guide Catheters II-32
Guidewires II-32
5. PRODUCT APPROVALS II-33
Conditional IDE Approval for ORBIT II Clinical Trial with
Diamondback 360® System II-33
US FTC Approves Getinge and Datascope Merger II-33
Xtent Obtains CE Mark for Custom NX Drug-Eluting Stent System II-34
Invatec Obtains CE Mark for IN.PACT Falcon Paclitaxel-Eluting
PTCA Balloon Catheter II-34
Medtronic Obtains Approval for Endeavor in Japan II-34
Atrium Medical Gains EU Approval for Cinatra(TM) II-34
Boston Scientific Obtains FDA Approval for TAXUS® Liberte® II-35
Boston Scientific Obtains FDA Approval for Taxus® Express2(TM) II-35
Health Canada Approves Abbott's XIENCE V® II-35
Angiotech Receives CE Certification for Zilver® PTX® Stent II-35
NMT Medical Obtains PMA Approval from US FDA for STARFlex®
Implant II-35
Cordis Receives FDA Approval for a Smaller Version of CYPHER®
Stent II-36
Boston Scientific Receives CE Mark for PROMUS® Element(TM) II-36
Biosensors International Obtains CE Mark for Small- Diameter
BioMatrix Stent II-36
AGA Medical Receives CE Mark for AMPLATZER® Cardiac Plug II-37
AGA Medical Gains CE Mark Approval for AMPLATZER® Vascular
Plug III II-37
AGA Medical Gets CE Mark for AMPLATZER® Duct Occluder II II-37
Cook Medical Receives FDA Clearance for Balloon Dilatation
Catheter II-38
Cardiac Dimensions® Receives CE Mark for Carillontm Mitral
Contour Systemtm II-38
Medtronic Receives the US FDA Approval to Use Endeavor® Stent II-38
Boston Scientific to Market TAXUS® Liberte® Stent System in
Canada II-39
Global Therapeutics Receives CE Mark for Global Therapeutics
GTX Coronary Stent System II-39
OrbusNeich Obtains CE Mark II-39
Abbott's 2.25mm-Sized XIENCE(TM) V Drug Eluting Stent receives CE
Mark of Approval II-39
Cook Medical Gains CE Mark Approval for MiraFlex(TM) High Flow
Microcatheter II-40
Terumo Receives CE Certification for Nobori(TM) DEC Stent System II-40
Abbott Applies for Approval of XIENCE(TM) V in Japan II-40
Tryton Medical's Side-Branch Stent Achieves CE Mark Approval II-40
MIV Therapeutics Obtains DCGI Approval II-41
Cook Medical's Zilver Stent Receives Approval for Vascular Use
In Canada II-41
6. PRODUCT LAUNCHES II-42
Boston Scientific Introduces iCross Coronary Imaging Catheter II-42
Boston Scientific Launches TAXUS® Liberte® DES System in Japan II-42
Abbott Introduces VOYAGER(TM) NC Coronary Balloon Catheter II-42
Invatec Introduces Coronary Drug-Eluting Balloon Platform IN.PACT II-42
Terumo Launches Glidewire Advantage(TM) Peripheral Guidewire II-43
Invatec Launches REEF HPTM PTA Balloon Catheter II-43
Tryton Medical Launches Side-Branch Stent II-43
Terumo Interventional Systems Introduces Coronary Diagnostic
Catheters II-43
Medtronic Launches Endeavor Sprint Drug Eluting Stent II-44
Medtronic to Introduce Balloon Catheters and Coronary Stents II-44
Cordis Introduces SAVVY® and SLEEK(TM) Balloon Catheters II-44
Volcano Launches Integrated FFR and Rotational IVUS II-44
Medtronic Launches Defender Embolic Protection Filter II-45
Biosensors Introduces BioMatrix® Drug-Eluting Stent II-45
St. Jude Medical Unveils Refllexion Spiral XTM Catheter II-45
Volcano Launches PrimeWire(TM) Pressure Guidewire and s5-FFR
Option for Existing Fleet of s5 IVUS Consoles II-45
7. RECENT INDUSTRY ACTIVITY II-46
Medtronic to Acquire Invatec II-46
Lake Region Medical Acquires Brivant Medical II-46
Abbott Acquires Evalve II-46
Texcel and Circle Medical Announce Merger II-47
Volcano and Lumen Biomedical Enter into Distribution Agreement II-47
Volcano Enters into Alliance with Siemens Healthcare II-47
Spectranetics Acquires Embolic Protection Products from Kensey
Nash II-48
MEDRAD Merges With Possis Medical II-48
St. Jude Medical to Acquire RadiMedical II-48
St. Jude Medical Acquires EP MedSystems II-49
Volcano Takes Over Novelis II-49
Heraeus Vadnais Takes Over Synovis Life Technologies II-50
Novation Signs Deal with Medtronic for Endeavor Zotarolimus DES II-50
Boston Scientific Enter into Agreement with Trivitron II-50
Volcano and Royal Philips Electronics Sign North America
Resale Agreement II-50
MMDIA Receives Patent Allowance for BetaWire(TM) Guidewire II-50
Cordis to Market ClearStream Technologies' Catheters II-51
Abbott Laboratories Acquires Nova Science II-51
8. FOCUS ON SELECT PLAYERS II-52
Abbott Laboratories (US) II-52
Abbott Vascular (US) II-52
AGA Medical Holdings, Inc. (US) II-53
B. Braun Melsungen AG (Germany) II-53
Biosensors International Group Ltd. (Singapore) II-53
Boston Scientific Corp. (US) II-54
Cardiac Dimensions, Inc. (US) II-54
COOK Medical, Inc. (US) II-54
Cordis Corp. (US) II-55
Edwards Lifesciences Corp. (US) II-55
Eurocor GmbH (Germany) II-56
ev3, Inc. (US) II-56
Goodman Co., Ltd. (Japan) II-56
Medtronic, Inc. (US) II-57
Medtronic Vascular, Inc. (US) II-57
Merit Medical Systems, Inc. (US) II-57
NMT Medical (US) II-58
Spectranetics Corp. (US) II-58
St. Jude Medical, Inc. (US) II-59
Terumo Corp. (Japan) II-59
Terumo Medical Corporation (Japan) II-59
Thermocore Medical Limited (UK) II-60
Translumina GmbH (Germany) II-60
Vascular Solutions, Inc. (US) II-60
Volcano Corp. (US) II-61
9. GLOBAL MARKET PERSPECTIVE II-62
Table 11: World Recent Past, Current & Future Analysis for
Interventional Cardiology Devices by Geographic Region - US,
Japan, Europe, Asia-Pacific (Excl. Japan) and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) II-62
Table 12: World 10-Year Perspective for Interventional
Cardiology Devices by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Japan, Europe, Asia-Pacific (Excl.
Japan) and Rest of World Markets for Years 2006, 2009 and 2015
(includes corresponding Graph/Chart) II-63
Table 13: World Recent Past, Current & Future Analysis for
Interventional Cardiology Devices by Product Segment -Coronary
Stents, Peripheral Devices, Angioplasty Catheters,
Intravascular Ultrasound, Vascular Sealings and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2015 (includes corresponding
Graph/Chart) II-64
Table 14: World 10-Year Perspective for Interventional
Cardiology Devices by Product Segment - Percentage Breakdown
of Dollar Sales for Coronary Stents, Peripheral Devices,
Angioplasty Catheters, Intravascular Ultrasound, Vascular
Sealings and Others Markets for Years 2006, 2009 and 2015
(includes corresponding Graph/Chart) II-65
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Coronary Artery Disease III-1
Table 15: The Ten Leading Causes of Death in the US
(includes corresponding Graph/Chart) III-1
Coronary Heart Disease Statistics III-2
Rising Obesity Levels Increase Number of Interventional
Cardiology Procedures III-2
Current and Future Analysis III-2
Market Overview III-2
Coronary Stents Market III-3
Table 16: Angioplasty and Stent Procedures Performed in the
US: 2006-2011 (In Thousands) (includes corresponding
Graph/Chart) III-3
Table 17: US Coronary Stents Market (2006-2011): Number of
Stents Used in Angioplasty Procedures by Stent Type (in
Thousands) (includes corresponding Graph/Chart) III-4
The Emergence, Rise, Fall and Re-emergence of Drug Eluting
Stents III-4
The Angioplasty and Stents Debate Continues III-4
The Role of Pharmacists III-5
The Huge Potential III-5
Table 18: US Drug Eluting Stents Market (2009): Market
Share Breakdown of Value Sales by Leading Brands - Cypher,
Endeavor, Taxus, Promus and Xience (includes corresponding
Graph/Chart) III-6
Product Approvals III-6
Product Launches III-9
Strategic Corporate Developments III-10
Select Players III-13
B.Market Analytics III-20
Table 19: US Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-20
2. JAPAN III-21
A.Market Analysis III-21
Current and Future Analysis III-21
Market Overview III-21
Coronary Stents - The Leading IC Device Segment III-21
US Companies Lead Japanese IC Device Market III-21
Table 20: Japanese Coronary Stents Market (2007): Market
Share Breakdown of Value Sales by Major Players - Johnson &
Johnson, Boston Scientific, Abbott/Guidant, Medtronic and
Others (in US$ Million) (includes corresponding
Graph/Chart) III-22
Table 21: Japanese Bare-Metal Stents Market (2007): Market
Share Breakdown of Value Sales by Major Players -
Medtronic, Abbott/Guidant, Johnson & Johnson, Boston
Scientific,and Others (includes corresponding Graph/Chart) III-22
Drug-Eluting Stents III-22
Table 22: Japanese Coronary Drug-Eluting Stents Market
(2009): Market Share Breakdown of Value Sales by Major
Player Johnson & Johnson, Boston Scientific and Medtronic III-23
Product Approvals III-23
Product Launches III-24
Select Players III-24
B.Market Analytics III-26
Table 23: Japanese Recent Past, Current & Future Analysis
for Interventional Cardiology Devices Annual Sales Figures
in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-26
3. EUROPE III-27
A.Market Analysis III-27
Current and Future Analysis III-27
Market Overview III-27
The DES Market III-27
Table 24: European Coronary Stent Market (2007): Market
Share Breakdown of Value Sales by Company - Boston
Scientific, Johnson & Johnson, Medtronic, Abbott and
Others (includes corresponding Graph/Chart) III-28
Table 25: European Coronary Drug-Eluting Stent Market
(2007): Market Share Breakdown of Value Sales by Company -
Boston Scientific, Johnson & Johnson, Medtronic, Abbott
and Others (includes corresponding Graph/Chart) III-28
Table 26: European Coronary Bare-Metal Stent Market
(2007): Market Share Breakdown of Value Sales by Company -
Abbott, Medtronic, Boston Scientific, Johnson & Johnson,
and Others (includes corresponding Graph/Chart) III-28
Technology Innovation Drives PCI Devices Market in Western
Europe III-29
Table 27: Western Europe PCI (Percutaneous Coronary
Intervention) Market (2008): Percentage Breakdown of Sales
in Value Terms for Boston Scientific, Cordis, Medtronic,
Abbott and Others (includes corresponding Graph/Chart) III-29
Table 28: Western Europe Coronary Stent Market (2008) by
Stent Type: Percentage Breakdown of Sales in Value Terms
for Drug-Eluting Stents and Bare Metal Stents III-30
Table 29: Western Europe Coronary Stent Market (2008) by
Company: Percentage Breakdown of Sales in Value Terms for
Boston Scientific, Cordis, Medtronic, Abbott and Others
(includes corresponding Graph/Chart) III-30
Table 30: Western Europe Angioplasty Balloon Market (2008)
by Company: Percentage Breakdown of Sales in Value Terms
for Biotronik, ClearStream, Invatec and Others (includes
corresponding Graph/Chart) III-30
Table 31: Western Europe Coronary Catheters Market (2008)
by Company: Percentage Breakdown of Sales in Value Terms
for Cordis, Boston Scientific, Medtronic, Abbott, St. Jude
Medical and Others (includes corresponding Graph/Chart) III-31
Table 32: Western Europe Coronary Guidewires Market (2008)
by Company: Percentage Breakdown of Sales in Value Terms
for Cordis, Boston Scientific, Abbott, Medtronic, St. Jude
Medical and Others (includes corresponding Graph/Chart) III-31
Table 33: Western Europe Balloon Inflators Market (2008)
by Company: Percentage Breakdown of Sales in Value Terms
for Medtronic, Abbott, Merit Medical, B. Braun and Others
(includes corresponding Graph/Chart) III-31
Table 34: Western Europe Embolic Protection Devices Market
(2008) by Company: Percentage Breakdown of Sales in Value
Terms for Boston Scientific, Medtronic, Abbott, St. Jude
Medical and Others (includes corresponding Graph/Chart) III-32
Product Approvals III-32
Product Launches III-36
Strategic Corporate Developments III-38
Select Players III-38
B.Market Analytics III-40
Table 35: European Recent Past, Current & Future Analysis
for Interventional Cardiology Devices Annual Sales Figures
in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-40
4. ASIA-PACIFIC III-41
A.Market Analysis III-41
Current and Future Analysis III-41
Market Overview III-41
Table 36: Asia-Pacific Drug Eluting Stents Market (2007):
Percentage Breakdown of Value Sales for China, Korea,
India, Australia and Others (includes corresponding
Graph/Chart) III-41
Table 37: Asia-Pacific Drug Eluting Stents Market (2007):
Market Share Breakdown by Leading Players - Microport,
Cordis, JW Medical ,Boston Scientific and Others (includes
corresponding Graph/Chart) III-42
B.Market Analytics III-42
Table 38: Asia-Pacific Recent Past, Current & Future
Analysis for Interventional Cardiology Devices by Geographic
Region - China, India, Korea, and Rest of Asia-Pacific
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-42
Table 39: Asia-Pacific 10-Year Perspective for
Interventional Cardiology Devices by Geographic Region -
Percentage Breakdown of Dollar Sales for China, India,
Korea, and Rest of Asia-Pacific Markets for Years 2006,
2009, and 2015 (includes corresponding Graph/Chart) III-43
4a. CHINA III-44
A.Market Analysis III-44
Current and Future Analysis III-44
Market Overview III-44
Growth Drivers and Restrains III-44
Healthcare Reforms to Drive Drug-Eluting Stents Growth III-45
B.Market Analytics III-45
Table 40: Chinese Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-45
4b. INDIA III-46
A.Market Analysis III-46
Current and Future Analysis III-46
Market Overview III-46
Imported Stents Hold Great Prospects III-46
Availability of Enhanced DES Ensures Quality Care for Heart
Patients III-46
Product Approval III-47
Strategic Corporate Developments III-47
B.Market Analytics III-48
Table 41: Indian Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-48
4c. KOREA III-49
A.Market Analysis III-49
Current and Future Analysis III-49
Market Outlook III-49
Market Overview III-49
US Companies Dominate Supply Landscape III-49
Korean Imports of Interventional Cardiology Devices:
Breakdown by Select Countries of Origin III-50
Table 42: Korean Interventional Coronary Artery Devices
Market (2007-2009): Number of Procedures for Diagnostic
Angiography, and PTCA Procedures (In Thousands) (includes
corresponding Graph/Chart) III-50
B.Market Analytics III-51
Table 43: Korean Recent Past, Current & Future Analysis for
Interventional Cardiology Devices by Product Segment - Drug
Eluting Stents, Intravascular Ultrasound, Guiding Catheters,
Balloon Catheters, PTCA Guidewires, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2015 (includes corresponding
Graph/Chart) III-51
Table 44: Korean 10-Year Perspective for Interventional
Cardiology Devices by Product Segment - Percentage Breakdown
of Dollar Sales for Drug Eluting Stents, Intravascular
Ultrasound, Guiding Catheters, Balloon Catheters, PTCA
Guidewires, and Others Markets for Years 2006, 2009, and
2015 (includes corresponding Graph/Chart) III-52
4d. REST OF ASIA-PACIFIC III-53
A.Market Analysis III-53
Current and Future Analysis III-53
Product Approval III-53
Select Player III-53
B.Market Analytics III-54
Table 45: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Interventional Cardiology Devices Annual Sales
Figures in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-54
5. REST OF WORLD III-55
A.Market Analysis III-55
Current and Future Analysis III-55
Product Approvals III-55
Product Launch III-56
B.Market Analytics III-56
Table 46: Rest of World Recent Past, Current & Future
Analysis for Interventional Cardiology Devices Annual Sales
Figures in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-56
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 73 (including Divisions/Subsidiaries - 82)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 48
Canada 3
Japan 7
Europe 14
Germany 7
The United Kingdom 4
Italy 1
Rest of Europe 2
Asia-Pacific (Excluding Japan) 8
Africa 2
------------------------------------------
To order this report:
Cardiovascular Devices Industry: Global Interventional Cardiology Industry
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
